Antidiabetic Drugs can Worsen T2DM

Type 2 diabetes is fundamentally a disease of insulin resistance and progressive metabolic dysfunction. Yet many traditional antidiabetic drugs focus primarily on lowering blood glucose numbers—sometimes in ways that can increase weight, drive higher insulin levels, stress pancreatic beta cells, or fail to address the root drivers of the condition.

This ebook examines the mechanisms by which certain classes of antidiabetic medications (particularly older agents such as sulfonylureas and insulin) may contribute to weight gain, ongoing hyperinsulinemia, reduced treatment durability, and potential long-term worsening of the metabolic state. It contrasts these effects with therapies and approaches that support weight reduction, improve insulin sensitivity, and better align with the pathophysiology of type 2 diabetes.

Written for clinicians, healthcare professionals, and informed patients, Antidiabetic Drugs Can Worsen T2DM provides a clear, evidence-based discussion of treatment trade-offs, the importance of addressing insulin resistance, and why medication choices matter beyond short-term glycemic control. The goal is not to reject pharmacotherapy, but to encourage more thoughtful, root-cause-oriented care that supports lasting metabolic health.